What is the sensitivity of Fungitell (beta-D-glucan assay) for detecting invasive fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sensitivity of Fungitell (Beta-D-Glucan Assay) for Detecting Invasive Fungal Infections

The Fungitell beta-D-glucan assay has a sensitivity of approximately 75-80% for detecting invasive fungal infections in adults, with sensitivity varying by patient population and specific fungal infection type. 1

Overview of Beta-D-Glucan Testing

Beta-D-glucan (BDG) is a cell wall component found in most pathogenic fungi, including Candida species, Aspergillus species, and Pneumocystis jirovecii. The Fungitell assay (manufactured by Associates of Cape Cod, East Falmouth, Massachusetts) is FDA-approved as an adjunct to cultures for diagnosing invasive fungal infections.

Sensitivity by Population:

  1. Adult Patients:

    • Meta-analyses show pooled sensitivity of 75-80% for invasive candidiasis 1
    • Sensitivity of 77.8% for overall invasive fungal infections 2
    • Varies by specific fungal infection:
      • 68% for invasive pulmonary aspergillosis
      • 85.2% for fungal bloodstream infections
      • 100% for Pneumocystis jirovecii pneumonia 2
  2. Neonatal Patients:

    • Higher sensitivity in neonates compared to adults
    • 89% sensitivity (95% CI: 80-94%) at 80 pg/mL threshold
    • 81% sensitivity (95% CI: 71-88%) at 120 pg/mL threshold 1
    • In proven neonatal invasive candidiasis, sensitivity reaches 99% at 80 pg/mL threshold 1
  3. Pediatric Transplant Patients:

    • Limited utility in children receiving antifungal prophylaxis post-hematopoietic cell transplantation
    • Sensitivity as low as 0% in some studies of prophylaxed patients 3

Factors Affecting Sensitivity

Several factors can influence the sensitivity of the Fungitell assay:

  1. Prior antifungal therapy:

    • Antifungal agents may reduce diagnostic sensitivity 1
    • Particularly problematic in patients receiving prophylactic antifungals 3
  2. Type of infection:

    • Higher sensitivity for bloodstream infections (85.2%) 2
    • Lower sensitivity for deep-seated candidiasis without candidemia (21% for blood cultures vs. 67% for BDG) 1
  3. Cut-off value:

    • Standard manufacturer cut-off is 80 pg/mL
    • Higher cut-offs (e.g., 120 pg/mL) decrease sensitivity but increase specificity 1
  4. Study design:

    • Case-control studies show higher sensitivity than consecutive cohort studies 1, 4

Clinical Implications

The Fungitell assay has important clinical applications:

  • Early detection: Can identify invasive candidiasis days to weeks before positive blood cultures 1
  • High negative predictive value: Useful for ruling out invasive fungal infections (NPV >97%) 5
  • Complementary to blood cultures: Particularly valuable for deep-seated candidiasis where blood cultures have poor sensitivity (21% vs. 67% for BDG) 1

Limitations and Pitfalls

Important limitations to consider when interpreting Fungitell results:

  1. False positives: Common causes include:

    • Hemodialysis with cellulose membranes
    • Administration of blood products (albumin, immunoglobulins)
    • Certain antibiotics (e.g., piperacillin-tazobactam)
    • Bacterial infections, particularly gram-positive bacteremia 5
  2. Not specific for Candida: Detects cell wall components of various fungi

    • Cannot distinguish between different fungal pathogens
    • Positive in infections with Aspergillus, Pneumocystis, and other fungi 1
  3. Variable performance across studies:

    • Considerable heterogeneity in study results, even when using the same assay 4
    • Performance varies by clinical setting and patient population

Summary

The Fungitell beta-D-glucan assay demonstrates good sensitivity (75-80% in adults, up to 89% in neonates) for detecting invasive fungal infections, with higher sensitivity for bloodstream infections and Pneumocystis pneumonia. Its high negative predictive value makes it particularly useful for excluding invasive fungal infections, but positive results must be interpreted with caution due to potential false positives. The test performs best when used as part of a comprehensive diagnostic approach alongside traditional culture methods.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.